Diabetic foot ulcer clinical trials
Showing 51–71 of 71 active trials. Describe your situation to see which ones you may be eligible for.
- Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence
- Non-Invasive Testing to Evaluate Wound Healing in Diabetes
- Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers
- A Real-World Registry of Chronic Wounds and Ulcers
- A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
- Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.
- Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management
- CARE-D-FOOT-Nav Pilot
- A Study to Evaluate Microvessel Ultrasound Imaging of Wound Healing in Patients With Chronic Ulcers
- Transverse Tibial Bone Transport (TTT) in the Management of Chronic Diabetic Lower Extremity Wounds
- Placental Cells for Diabetic Foot Ulcers
- Evaluating the Efficacy of FoundationDRS Solo in Addition to Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers
- BIO-SEE: Bioburden Imaging Outcome Study for Equivalence Evaluation
- Adipose-Derived Stromal Cells (ASC's) for Pressure Ulcers
- Case Series of StimLabs Dehydrated Human Umbilical Cord Particulate for Acute and Chronic Wounds
- A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers
- Tele-Exercise Platform for Plantar Wound Healing
- Kerecis Real-World Fish Skin Graft Registry
- Clinical Registry Collecting Real World Evidence on Wound Care Treatments
- NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers
- Performance of WOUNDCHEK Bacterial Status
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.